With its universities, Los Angeles graduates 20% more biotech students than any other university cluster, deploys an average total research expenditures deemed the second highest in the nation and has… read more →
In his speech at the groundbreaking ceremony for the USC Michelson Center on October 23, 2014, Dr. Gary K. Michelson emphasized that the rewards of tomorrow require planning and action… read more →
Biotech will be the fastest growing sector of the global economy for the next 20 to 30 years. Los Angeles universities produce over 5,000 graduates in the sciences, engineering and… read more →
In honor of Veteran’s Day, the Michelson Medical Research Foundation would like to call attention to one of the most debilitating casualties faced by men and women in the armed… read more →
The amount of beneficial bacteria in breast milk varies depending on the mode of delivery, gestational age at birth, and the lactation stage of the mother. Breast milk is a… read more →
Hepatitis C (HCV) is an infectious disease, often asymptomatic, affecting primarily the liver. As a chronic infection, it can lead to liver scarring, cirrhosis and, ultimately, liver failure, liver cancer,… read more →
It costs an average of $350 billion to bring a drug to market. For every drug made available to the consumer, nine are abandoned during development. Given these costs, most… read more →